NCT05171075 2026-04-17
MAGNOLIA
Anthos Therapeutics, Inc.
Phase 3 Terminated
Anthos Therapeutics, Inc.
Beth Israel Deaconess Medical Center
Regeneron Pharmaceuticals
Case Comprehensive Cancer Center
Regeneron Pharmaceuticals
University Hospital, Brest